Literature DB >> 16635998

Patient Alert to detect ICD lead failure: efficacy, limitations, and implications for future algorithms.

Dirk Vollmann1, Ali Erdogan, Ewald Himmrich, Jörg Neuzner, Daniel Becker, Christina Unterberg-Buchwald, Johannes Sperzel.   

Abstract

AIMS: An algorithm that alerts implantable cardioverter-defibrillator (ICD) patients, in case of abnormal lead impedance (Patient Alerttrade mark, Medtronic), may help to recognize lead dysfunction. We aimed to determine the utility of Patient Alert for ICD lead-failure detection in a prospective study. METHODS AND
RESULTS: Three hundred and sixty ICD patients were followed for 22+/-14 months. Patient Alert was active for pacing impedance <200 and >2000-3000 Omega, and high-voltage conductor impedance <10-20 and >200 Omega. Ten alert events and a total of 29 severe system complications occurred. Patient Alert detected three of 10 ICD lead failures, with a positive predictive value (PPV) of 77.8% for any severe system complication. Retrospective analysis identified 23 patients with a sensing integrity counter (SIC) >300 and revealed an additional four prior undetected lead defects. SIC detected ICD lead failure with 92.9% sensitivity and a PPV of 59.1%. Eight of nine patients with a false-positive SIC had an integrated bipolar lead. Patient Alert combined with SIC detected all ICD lead failures and 71.4% of all severe lead complications.
CONCLUSIONS: Patient Alert, based on daily lead-impedance measurement, detected one-third of all ICD lead failures. Combined use with continuous lead integrity monitoring (SIC) increased sensitivity to 100%. Integrated bipolar leads may yield a false-positive SIC. Incorporating SIC and automated pace/sense threshold measurement may improve Patient Alert sensitivity for severe lead complications.

Entities:  

Mesh:

Year:  2006        PMID: 16635998     DOI: 10.1093/europace/eul023

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  8 in total

1.  Remote monitoring in implantable defibrillator therapy.

Authors:  D A M J Theuns; L S Jordaens
Journal:  Neth Heart J       Date:  2008-02       Impact factor: 2.380

2.  Can we predict and prevent adverse events related to high-voltage implantable cardioverter defibrillator lead failure?

Authors:  Renato Pietro Ricci; Carlo Pignalberi; Barbara Magris; Stefano Aquilani; Vito Altamura; Loredana Morichelli; Antonio Porfili; Laura Quarta; Fabio Saputo; Massimo Santini
Journal:  J Interv Card Electrophysiol       Date:  2011-09-01       Impact factor: 1.900

3.  Use of remote monitoring in the management of system-related complications in implantable defibrillator patients.

Authors:  D A M J Theuns; L Jordaens
Journal:  Neth Heart J       Date:  2012-02       Impact factor: 2.380

4.  Contributions of remote monitoring to the follow-up of implantable cardioverter-defibrillator leads under advisory.

Authors:  Laurence Guédon-Moreau; Philippe Chevalier; Christelle Marquié; Claude Kouakam; Didier Klug; Dominique Lacroix; Francois Brigadeau; Salem Kacet
Journal:  Eur Heart J       Date:  2010-06-30       Impact factor: 29.983

5.  Inappropriate detection of an intraventricular conduction delay as a lead failure due to an increase in the sensing integrity counter in a patient with a cardiac resynchronization therapy-defibrillator.

Authors:  Kentaro Ozu; Hitoshi Minamiguchi; Shozo Konishi; Hiroya Mizuno; Yasushi Sakata
Journal:  HeartRhythm Case Rep       Date:  2020-10-24

6.  Patient alerting features in implantable defibrillators.

Authors:  Dirk Vollmann; Markus Zabel; Johnson Francis
Journal:  Indian Pacing Electrophysiol J       Date:  2008-02-01

Review 7.  Remote monitoring and follow-up of pacemakers and implantable cardioverter defibrillators.

Authors:  Haran Burri; David Senouf
Journal:  Europace       Date:  2009-06       Impact factor: 5.214

8.  Generator and lead-related complications of implantable cardioverter defibrillators.

Authors:  Ahmad Yaminisharif; Nader Soofizadeh; Akbar Shafiee; Ali Kazemisaeid; Arash Jalali; Ali Vasheghani-Farahani
Journal:  Int Cardiovasc Res J       Date:  2014-04-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.